Adial Pharmaceuticals Inc... (ADILW)
NASDAQ: ADILW
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jul 27, 2023, 9:52 PM
Adial Pharmaceuticals WT EXP 073123 Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.75M | 5.2M | 3.29M | 5.03M | 2.83M | 315.88K | 1.22M | 2.31M | 4M | 5.75M | 9.16M | 12.69M | 6.06M | 7.18M | 5.21M | 5.64M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 981.83K | 1.09M | 1.12M | 1.34M | 1.53M | 1.73M | 1.73M | n/a | -601.01K | n/a | n/a | n/a | -613.91K | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | -3.91K | -0.00 | -0.00 | n/a | 455K | n/a | n/a | n/a | -158.91K | 1.55M | 1.55M | 1.55M |
Receivables | n/a | n/a | n/a | n/a | n/a | 350K | 737.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 308.24K | 409.81K | 188.6K | 311.36K | 371.6K | 469.61K | 91.37K | 223.36K | 349.44K | 504.1K | 194.05K | 265.9K | 389.5K | 569.78K | 147.07K | 297.51K |
Total Current Assets | 4.06M | 5.62M | 3.82M | 5.34M | 3.2M | 1.14M | 2.05M | 2.96M | 4.78M | 6.77M | 9.94M | 12.96M | 6.46M | 7.99M | 5.59M | 6.17M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | 3.91K | n/a | n/a | 228.72K | 244.42K | 259.83K | 274.95K | 289.79K | 304.36K | 320.61K | 332.75K | 312.84K |
Goodwill & Intangibles | 3.35K | 3.49K | 3.63K | 3.77K | 3.91K | 4.05K | 4.2K | 708.31K | 708.45K | 708.59K | 708.73K | 708.87K | 709.01K | 591.68K | 591.82K | 591.96K |
Total Long-Term Assets | 985.18K | 1.09M | 1.13M | 1.35M | 1.54M | 1.73M | 1.73M | 937.03K | 952.87K | 968.41K | 983.68K | 998.66K | 1.01M | 2.46M | 2.47M | 2.45M |
Total Assets | 5.04M | 6.71M | 4.95M | 6.68M | 4.74M | 2.87M | 3.78M | 3.9M | 5.73M | 7.74M | 10.92M | 13.96M | 7.47M | 10.45M | 8.06M | 8.63M |
Account Payables | 250.13K | 318.12K | 316.73K | 177.47K | 127.39K | 81.92K | 111.7K | 530.14K | 276.41K | 278.2K | 617.78K | 415.09K | 286.19K | 185.19K | 477.41K | 637.4K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.38M | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 56.83K | 54.96K | 53.14K | 51.35K | n/a | 47.82K | 46.09K | 29.09K |
Other Current Liabilities | 405.25K | 510.93K | 81.58K | 196.12K | 525.69K | 92.15K | 282.34K | 114.99K | 1.02M | 639.93K | 644.14K | 1.3M | 1.87M | 1.23M | 1.36M | 232.98K |
Total Current Liabilities | 975.86K | 829.05K | 671.88K | 562.73K | 653.08K | 528.18K | 461.75K | 1.8M | 1.79M | 1.33M | 1.87M | 2.17M | 2.72M | 1.96M | 2.21M | 2.04M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 165.29K | 179.7K | 193.8K | n/a | 220.25K | 227.19K | 239.5K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | 506K | 492K | 651.71K | 712.3K | 674.2K | 1.01M | 847.76K | 566.29K | 486.51K |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | 437.00 | n/a | n/a | 663.94K | 665.44K | 1.01M | 1.1M | 1.09M | 1.24M | 1.29M | 1.02M | 965.52K |
Total Liabilities | 975.86K | 829.05K | 671.88K | 562.73K | 653.51K | 528.18K | 461.75K | 2.46M | 2.46M | 2.33M | 2.96M | 3.26M | 3.97M | 3.25M | 3.23M | 3.01M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 193.8K | 207.38K | 220.25K | 232.84K | 245.15K | 256.96K | 268.07K | 273.29K | 313K |
Book Value | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value Per Share | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 6.47K | 6.4K | 4.29K | 4.05K | 1.66K | 1.22K | 1.2K | 28.52K | 26.69K | 26.85K | 25.85K | 23.72K | 20.95K | 20.45K | 18.41K | 17.27K |
Retained Earnings | -82M | -79.92M | -77.73M | -75.27M | -68.8M | -66.88M | -65.49M | -66.58M | -63.67M | -60.81M | -57.7M | -53.85M | -50.94M | -45.11M | -40.79M | -36.35M |
Comprehensive Income | n/a | n/a | n/a | 0.00 | n/a | n/a | 0.00 | n/a | 0.00 | n/a | 0.00 | n/a | -0.00 | n/a | n/a | n/a |
Shareholders Equity | 4.07M | 5.88M | 4.28M | 6.12M | 4.08M | 2.34M | 3.32M | 1.44M | 3.28M | 5.41M | 7.96M | 10.71M | 3.51M | 7.2M | 4.83M | 5.62M |
Total Investments | 981.83K | 1.09M | 1.12M | 1.34M | 1.53M | 1.73M | 1.73M | n/a | -601.01K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |